Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Digital Therapeutics Market, by End Use
1.4.2 North America Digital Therapeutics Market, by Application
1.4.3 North America Digital Therapeutics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Restraints:
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Business Expansions
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Mar – 2021, Mar) Leading Players
Chapter 4. North America Digital Therapeutics Market by End Use
4.1 North America Patients Market by Country
4.2 North America Providers Market by Country
4.3 North America Payers Market by Country
4.4 North America Employers Market by Country
4.5 North America Other End Use Market by Country
Chapter 5. North America Digital Therapeutics Market by Applications
5.1 North America Diabetes Applications Market by Country
5.2 North America CNS Disease Applications Market by Country
5.3 North America Respiratory Diseases Applications Market by Country
5.4 North America Smoking Cessation Applications Market by Country
5.5 North America Obesity Applications Market by Country
5.6 North America CVD Applications Market by Country
5.7 North America Other Applications Market by Country
Chapter 6. North America Digital Therapeutics Market by Country
6.1 US Digital Therapeutics Market
6.1.1 US Digital Therapeutics Market by End Use
6.1.1.1.1 US Digital Therapeutics Market by Applications
6.2 Canada Digital Therapeutics Market
6.2.1 Canada Digital Therapeutics Market by End Use
6.2.2 Canada Digital Therapeutics Market by Applications
6.3 Mexico Digital Therapeutics Market
6.3.1 Mexico Digital Therapeutics Market by End Use
6.3.2 Mexico Digital Therapeutics Market by Applications
6.4 Rest of North America Digital Therapeutics Market
6.4.1 Rest of North America Digital Therapeutics Market by End Use
6.4.2 Rest of North America Digital Therapeutics Market by Applications
Chapter 7. Company Profiles
7.1 ResMed, Inc. (Propeller Health)
7.1.1 Company Overview
7.1.1 Financial Analysis
7.1.2 Segmental and Regional Analysis
7.1.3 Research & Development Expense
7.1.4 Recent strategies and developments:
7.1.4.1 Approvals and Trials:
7.1.4.2 Partnerships, Collaborations, and Agreements:
7.2 Teladoc Health, Inc. (Livongo Health)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Recent strategies and developments:
7.2.3.1 Partnerships, Collaborations, and Agreements:
7.2.3.2 Acquisition and Mergers:
7.3 Noom, Inc.
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Partnerships, Collaborations, and Agreements:
7.4 Omada Health, Inc.
7.4.1 Company Overview
7.4.2 Recent strategies and developments:
7.4.2.1 Partnerships, Collaborations, and Agreements:
7.4.2.2 Acquisition and Mergers:
7.4.2.3 Product Launches and Product Expansions:
7.5 Welldoc, Inc.
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 Canary Health
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Partnerships, Collaborations, and Agreements:
7.6.2.2 Business Expansions:
7.7 Mango Health, Inc. (TrialCard, Incorporated)
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Partnerships, Collaborations, and Agreements:
7.8 2Morrow, Inc.
7.8.1 Company Overview
7.9 Pear Therapeutics, Inc.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Partnerships, Collaborations, and Agreements:
7.9.2.2 Acquisition and Mergers:
7.9.2.3 Product Launches and Product Expansions:
7.10. Mindstrong, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:
Unique Offerings 